SPECIAL FOCUS: Total Joint ArthroplastyThe cost of infection after total joint arthroplastyMulder, Andrew; Jaafar, Sami; Markel, David C.Author Information Detroit Medical Center and Providence Hospital, Detroit, MI Financial Disclosure: Dr. Markel is a consultant for Stryker. The authors report no financial conflicts of interest. Correspondence to David C. Markel, MD, DMC-Providence Orthopaedic Residency, Orthopaedics Providence Hospital, 22250 Providence Drive #401, Southfield, MI 48075 Tel: +248 349 7015; fax: +248 569 0364; e-mail: email@example.com Current Orthopaedic Practice: November/December 2012 - Volume 23 - Issue 6 - p 554-559 doi: 10.1097/BCO.0b013e318271c2ad Buy Metrics Abstract Total joint arthroplasty of the hip and knee are commonly performed procedures with excellent clinical results and survivorship of nearly 80% at 20 years for hips and up to 90% at 15 years for knees. Despite these excellent outcomes, complications do occur and can prove costly to the patient, the physician, and the health care system. A particularly costly complication is the development of postoperative infection. What follows is an evaluation of the costs related to infection after total joint arthroplasty and a description of how those costs are being approached for containment. © 2012 Lippincott Williams & Wilkins, Inc.